PHR
Phreesia, Inc.NYSEHealthcare$8.37-0.36%ClosedMarket Cap: $504.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.48
P/S
1.05
EV/EBITDA
16.02
DCF Value
$-55.80
FCF Yield
12.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.2%
Operating Margin
22.4%
Net Margin
-4.2%
ROE
-6.5%
ROA
-4.9%
ROIC
22.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2026 | $127.1M | 133.3% | $108.7M | $-21.2M | $0.02 | — |
| FY 2026 | $480.6M | 85.2% | $107.6M | $-20.2M | $0.04 | — |
| Q3 2026 | $120.3M | 68.4% | $3.7M | $4.3M | $0.07 | — |
| Q2 2026 | $117.3M | 67.9% | $-1.5M | $654.0K | $0.01 | — |
| Q1 2026 | $115.9M | 67.2% | $-3.3M | $-3.9M | $-0.07 | — |
| Q4 2025 | $109.7M | 69.4% | $-7.6M | $-6.4M | $-0.11 | — |
| FY 2025 | $419.8M | 67.9% | $-58.1M | $-58.5M | $-1.02 | — |
| Q3 2025 | $106.8M | 67.7% | $-13.8M | $-14.4M | $0.65 | — |
| Q2 2025 | $102.1M | 67.9% | $-17.2M | $-18.0M | $-0.31 | — |
| Q1 2025 | $101.2M | 66.4% | $-19.4M | $-19.7M | $-0.35 | — |
| Q4 2024 | $95.0M | 66.6% | $-29.6M | $-30.6M | $-0.56 | — |
| FY 2024 | $356.3M | 65.2% | $-136.5M | $-136.9M | $-2.51 | — |